How Much Does Wegovy Cost Without Insurance?

The Wegovy cost without insurance has historically run in the range of roughly $1,300 to $1,350 per month, making it one of the most talked-about expenses in weight management today. Retail prices vary by pharmacy and change over time, so treat any figure as an estimate to verify. Understanding the full picture of Wegovy cost without insurance — including the newer direct self-pay pathway from the manufacturer — helps you plan financially and explore every available option to make this medication more affordable.

Wegovy (semaglutide 2.4 mg) is an FDA-approved injectable medication for chronic weight management in adults with obesity (BMI of 30 or greater) or overweight (BMI of 27 or greater) with at least one weight-related condition such as type 2 diabetes, hypertension, or high cholesterol. It is also approved to reduce the risk of major cardiovascular events in certain adults with established cardiovascular disease. Manufactured by Novo Nordisk, Wegovy works by mimicking the GLP-1 hormone to reduce appetite and increase feelings of fullness. It is available by prescription only, and dosing is individualized by your prescriber — do not attempt to self-manage the dose. Clinical trials published in the New England Journal of Medicine showed an average weight loss of approximately 15% of body weight over 68 weeks. For more on healthcare expenses, visit our costs guide.

Wegovy Pricing Breakdown Without Insurance

Wegovy is dispensed as a once-weekly injection in pre-filled pens, with a carton typically containing a four-week supply. The dose is started low and increased gradually under a prescriber’s supervision before reaching the maintenance dose. Importantly, the price is roughly the same across the different dose strengths, so stepping up to the full dose does not usually change the monthly cost. Here is how the cash pricing generally shakes out:

• Standard retail cash price: historically about $1,300 to $1,350 per 28-day supply, though pharmacies price independently and figures change — verify the current amount before you fill.
• Annual cost at retail without any discount: on the order of $15,000 to $16,000 per year.
• Manufacturer direct self-pay price: substantially lower than the retail list price for eligible cash-paying patients (see the next section).

Because each carton is roughly a month’s supply and the price is similar across dose strengths, the main variables are your pharmacy, any discount program, and whether you use the manufacturer’s self-pay channel. It is worth comparing prices at multiple pharmacies and checking discount tools like GoodRx or RxSaver, though savings on brand-name biologics are typically modest.

Novo Nordisk’s Direct Self-Pay Option (NovoCare)

One of the biggest changes to the affordability picture is the manufacturer’s direct-to-patient cash-pay pathway. In 2025, Novo Nordisk launched a self-pay option — offered through its NovoCare Pharmacy channel — that prices Wegovy well below the traditional retail list price for people paying cash. This pathway is aimed at patients whose insurance does not cover Wegovy, or who prefer to pay out of pocket rather than navigate coverage.

The exact self-pay price has changed since launch and may vary by dose and by promotional offer, so we are deliberately not quoting a single fixed number here — confirm the current amount directly with Novo Nordisk (novocare.com) or NovoCare Pharmacy before assuming a figure. What matters for planning is that a direct-pay route now exists that can bring the monthly cost far below the standard retail price, provided you meet the program’s requirements and fill through the designated pharmacy. As with any manufacturer program, terms and eligibility can be updated at any time.

Wegovy Cost With Insurance

Insurance coverage for Wegovy has been evolving as more employers and insurers recognize obesity as a chronic disease requiring medical treatment. However, coverage remains inconsistent.

Commercial insurance:

• Plans that cover anti-obesity medications may charge relatively modest monthly copays, often in the tens to low hundreds of dollars.
• Some plans place Wegovy on a specialty tier with coinsurance (a percentage of the cost), which can result in several hundred dollars per month.
• Many plans still exclude weight-loss medications entirely.
• Prior authorization is almost always required, including documentation of BMI, weight-related conditions, and prior attempts at diet and exercise.

Medicare:

• By law, Medicare Part D has historically excluded coverage of drugs used for weight loss alone.
• However, Medicare Part D can cover semaglutide when it is prescribed for a separately approved medical indication — most notably cardiovascular risk reduction in people with established cardiovascular disease, following Wegovy’s cardiovascular indication approval. It is the approved medical use, not obesity by itself, that opens the door to coverage.
• Legislative proposals to expand Medicare coverage of anti-obesity medications have been introduced over the years, but broad coverage for obesity alone remains limited as of 2026 — verify the current policy.

Medicaid:

• Coverage varies by state.
• Some states cover anti-obesity medications under their Medicaid formularies while others do not.

How to Save on Wegovy

Even at its high retail price, there are several ways to reduce your out-of-pocket Wegovy cost without insurance or with limited coverage:

Novo Nordisk Programs:

• Wegovy Savings Card: Available to people with commercial (employer or marketplace) insurance only. Eligible patients may pay a reduced amount per fill, subject to a maximum savings limit per fill. It cannot be used with government insurance such as Medicare or Medicaid, and is not for uninsured patients.
• NovoCare direct self-pay: The manufacturer’s cash-pay pathway (described above) for patients paying without insurance.
• Patient assistance: Novo Nordisk has offered patient-assistance support for eligible lower-income, uninsured patients. Eligibility criteria and availability change, so confirm the current program details directly with the manufacturer.

Other savings strategies:

• Pharmacy discount programs: GoodRx and similar tools may offer modest discounts on cash-pay pricing.
• Employer wellness programs: Some employers cover weight-management medications as part of comprehensive wellness benefits.
• Health savings accounts (HSAs) and flexible spending accounts (FSAs): You can generally use pre-tax dollars from these accounts to pay for a prescribed medication like Wegovy.
• Appeal insurance denials: If your insurer denies coverage, work with your physician to file an appeal, including documentation of your BMI, comorbidities, and prior weight-loss attempts.

What About Compounded Semaglutide?

During the earlier nationwide shortage of GLP-1 medications, some compounding pharmacies offered compounded semaglutide at a fraction of the brand price. That landscape has changed. After the FDA declared the semaglutide shortage resolved in early 2025, the regulatory allowance that had permitted large-scale compounding of copies wound down over the course of 2025. As a result, mass-produced compounded semaglutide is generally no longer permitted, and products still marketed that way carry legal and safety questions. The FDA has repeatedly warned about the risks of compounded GLP-1 products, including dosing errors and unverified ingredients. If you encounter a very cheap “semaglutide” offer, be cautious and discuss safety and legitimacy with your physician and pharmacist before using it.

Wegovy vs. Other GLP-1 Weight-Loss Medications: Cost Comparison

Several GLP-1 (and dual-agonist) medications are available for weight management or are used off-label. Approximate cash prices without insurance run in the following ballparks, though all of these figures move over time and are worth verifying:

• Wegovy (semaglutide 2.4 mg): roughly $1,300 to $1,350 per month at retail (lower via the manufacturer’s self-pay option).
• Ozempic (semaglutide, FDA-approved for type 2 diabetes; used off-label for weight loss): around $900 to $1,000+ per month.
• Zepbound (tirzepatide, FDA-approved for weight loss): roughly $1,000 to $1,300 per month, with a lower-cost manufacturer self-pay option in some cases.
• Mounjaro (tirzepatide, approved for type 2 diabetes; used off-label for weight loss): roughly $1,000 to $1,300 per month.
• Saxenda (liraglutide 3 mg): around $1,300 to $1,500 per month.
• Contrave (naltrexone-bupropion): roughly $100 to $300 per month.

Ozempic and Wegovy both contain semaglutide, but only Wegovy is FDA-approved specifically for chronic weight management. For a detailed comparison, see our guide on Ozempic vs. Wegovy. You can also explore how to get a prescription through our guide on Wegovy online prescriptions.

What Affects the Total Cost of Wegovy Treatment?

Beyond the medication itself, several additional expenses can affect your total investment in Wegovy treatment:

• Doctor visits: Initial evaluation and periodic follow-ups typically cost around $100 to $300 per visit without insurance. Most physicians recommend regular check-ins during treatment.
• Lab work: Baseline and periodic blood tests may be recommended and can cost roughly $50 to $200 without insurance.
• Nutritional counseling: Many physicians recommend concurrent dietary support. Sessions with a registered dietitian cost roughly $75 to $200 per visit without insurance.
• Duration of treatment: Wegovy is intended as a long-term medication. Research indicates that many patients regain weight after discontinuing GLP-1 medications, so ongoing use may be necessary to maintain results — a key factor in the total lifetime cost.

Is Wegovy Worth the Cost?

The clinical evidence supporting Wegovy for weight management is substantial:

• The STEP clinical trial program demonstrated average weight loss of roughly 15% of body weight over 68 weeks.
• The SELECT trial showed a meaningful reduction in major cardiovascular events in patients with established cardiovascular disease, which led to FDA approval for cardiovascular risk reduction.
• Improvements in blood pressure, cholesterol, blood sugar, and other metabolic markers were reported across trials.
• Quality-of-life improvements were documented in patient-reported outcome measures.

The value proposition depends on your individual circumstances, including the severity of your weight-related health conditions, the cost after insurance and savings programs, and your ability to maintain treatment long-term. This is a decision to make with your physician, not based on price alone.

Frequently Asked Questions

Will Wegovy ever get cheaper?

Generic semaglutide is not expected until Novo Nordisk’s patents expire, which is generally projected for the late 2020s to early 2030s. In the meantime, competition among GLP-1 and dual-agonist medications, plus manufacturer self-pay programs, has already begun to pull effective prices down for some patients. Confirm current pricing rather than relying on older figures.

Can I use Ozempic instead of Wegovy to save money?

Some physicians prescribe Ozempic off-label for weight loss because it contains the same active ingredient (semaglutide). Ozempic may be easier to get covered because it is FDA-approved for type 2 diabetes. However, using Ozempic off-label for weight loss without a diabetes diagnosis may not be covered, and it is not FDA-approved for weight management. Discuss the medical and cost trade-offs with your physician.

How long do I need to take Wegovy?

Wegovy is intended for long-term use. Studies show that patients who discontinue semaglutide tend to regain a substantial portion of the weight they lost. Your physician will help you determine the appropriate duration based on your response and health goals.

Are there any hidden costs with Wegovy?

Beyond the medication cost, budget for doctor visits, lab work, and managing side effects. Common side effects include nausea, vomiting, diarrhea, and constipation, which often improve over time. The gradual dose escalation your prescriber uses is designed to reduce side effects but means it takes some weeks to reach the full maintenance dose.

Final Thoughts on Wegovy Cost

The Wegovy cost without insurance is substantial, but the affordability picture in 2026 is more flexible than it was a few years ago, thanks to the manufacturer’s direct self-pay option, savings cards for the commercially insured, and gradually broadening coverage. Start by checking your insurance coverage, then explore the Novo Nordisk savings card (if you have commercial insurance) or the NovoCare self-pay route (if you are paying cash). If Wegovy remains unaffordable, discuss alternative medications and other evidence-based weight-management strategies with your physician. Because pricing and coverage change frequently, always confirm current details before you commit.

Sources

• U.S. Food & Drug Administration (FDA) — Wegovy (semaglutide) approvals; resolution of the GLP-1 shortage and compounding guidance
• Novo Nordisk / NovoCare — Wegovy list-price explanation, self-pay pricing, and savings offers (novocare.com)
• Medicare.gov and the Centers for Medicare & Medicaid Services (CMS) — Part D coverage rules for anti-obesity vs. approved-indication use
• New England Journal of Medicine — STEP and SELECT clinical trial results